A State-of-the-Art Pharmaceutical Research & Development Facility looking to raise INR 10 CR

Posted On: 09 / Mar / 2023
0 863

Deal Details

Annual

Deal Type

Equity (Fundraise)
Maximum Loan

Industry

Pharmaceuticals
Charge

Deal Status

Active

Deal Description

A State-of the-Art Pharmaceutical Research and Developement Facility which started in the year 2009. It is a contract research and manufacturing organization operating within the generic pharmaceutical market whilst providing a diverse portfolio of services to pharmaceutical and R&D Centers across the globe. Commissioned by experienced pharmaceutical professionals having wide global exposure and having capacity to develop ANDAs and First-To-File formulations.

The activities done are as follows:-

  1. Formulation development and Process Validiation
  2. Analytical method development and Method Valuation
  3. Technology Transfer to CMO
  4. Stability studies as per ICH Guidelines
  5. Manufacturing of Clinical/ Bio-Batch for BE/ Clinical Studies
  6. Commercial Manufacturing of Tablets, Pellets, Powders, and Sachets for export market with to Europe approved facility

Products which will be provided are as follows:-

  1. Tablets (Coated and Uncoated) = Immediate Release, Modified Release, Effervescent, Orodispersible, Chewable, and Bi-Layered Tablets
  2. Capsule
  3. Granules
  4. Pellets

The services that are offered are:-

  1. Research and Development
  2. Technology Transfer
  3. Stability
  4. Commercial Supply

The funds we are raising are required for:-

  1. Man Power
  2. Capex
  3. Bioequivalence Studies
  4. Dossier Acquisition
  5. New Product Development

The Revenue of the company during the previous years are as follows:-

  1. 2021-22 = ₹ 2.23 Cr
  2. 2020-21 = ₹ 4.24 Cr
  3. 2019-20 = ₹ 5.58 Cr

No Files Attached

Deal Value
10 Crore
Targeted Region
Asia Pacific

Revenue

2019-20
4.24 Crore
2020-21
2.24 Crore
2021-22
Undisclosed